Display options
Share it on

3 Biotech. 2013 Dec;3(6):439-459. doi: 10.1007/s13205-013-0117-5. Epub 2013 Feb 12.

Anti-cancer potential of flavonoids: recent trends and future perspectives.

3 Biotech

Priya Batra, Anil K Sharma

Affiliations

  1. Department of Biotechnology, MMEC, Maharishi Markandeshwar University, Mullana, Ambala, Haryana, 133207, India.
  2. Department of Biotechnology, MMEC, Maharishi Markandeshwar University, Mullana, Ambala, Haryana, 133207, India. [email protected].

PMID: 28324424 PMCID: PMC3824783 DOI: 10.1007/s13205-013-0117-5

Abstract

Cancer is a major public health concern in both developed and developing countries. Several plant-derived anti-cancer agents including taxol, vinblastine, vincristine, the campothecin derivatives, topotecan, irinotecan and etoposide are in clinical use all over the world. Other promising anti-cancer agents include flavopiridol, roscovitine, combretastatin A-4, betulinic acid and silvestrol. From this list one can well imagine the predominance of polyphenols, flavonoids and their synthetic analogs in the treatment of ovarian, breast, cervical, pancreatic and prostate cancer. Flavonoids present in human diet comprise many polyphenolic secondary metabolites with broad-spectrum pharmacological activities including their potential role as anti-cancer agents. A positive correlation between flavonoids-rich diet (from vegetables and fruits) and lower risk of colon, prostate and breast cancers lead to a question that whether flavonoids mediate the protective effects as chemopreventive agents or can interact with different genes and proteins to play role in chemotherapy. The current review emphasizes onto the therapeutic potential of flavonoids and their synthetic analogs as anti-cancer agents by providing new insights into the factors, regulation and molecular mechanisms along with their significant protein interactions.

Keywords: Anti-cancer; Breast cancer; Dietary flavonoids; Flavonoids; Health benefits; Therapeutic potential

References

  1. Jpn J Clin Oncol. 2009 Jun;39(6):352-9 - PubMed
  2. Oncogene. 2003 Jul 31;22(31):4851-9 - PubMed
  3. Biomacromolecules. 2004 Mar-Apr;5(2):547-52 - PubMed
  4. Am J Clin Nutr. 2001 Oct;74(4):418-25 - PubMed
  5. Molecules. 2010 Dec 09;15(12):9092-103 - PubMed
  6. Exp Eye Res. 2000 Nov;71(5):483-7 - PubMed
  7. Pharmacogn Rev. 2011 Jan;5(9):1-12 - PubMed
  8. Nutr Cancer. 1993;20(1):21-9 - PubMed
  9. Med Oncol. 2010 Dec;27(4):1346-58 - PubMed
  10. Exp Biol Med (Maywood). 2008 Sep;233(9):1066-80 - PubMed
  11. Toxicol In Vitro. 2006 Mar;20(2):187-210 - PubMed
  12. Eur J Pharmacol. 2010 Dec 15;649(1-3):84-91 - PubMed
  13. Biol Reprod. 2004 Apr;70(4):1188-95 - PubMed
  14. BMJ. 2004 Dec 18;329(7480):1447-50 - PubMed
  15. Biochem Pharmacol. 1997 Feb 21;53(4):587-96 - PubMed
  16. Carcinogenesis. 2002 Sep;23(9):1467-74 - PubMed
  17. Pharmacol Rep. 2009 Jan-Feb;61(1):67-75 - PubMed
  18. Int J Cancer. 2004 Jan 10;108(2):277-80 - PubMed
  19. Biomed Pharmacother. 2006 Nov;60(9):508-19 - PubMed
  20. J Biol Chem. 1987 Apr 25;262(12):5592-5 - PubMed
  21. Cardiovasc Res. 2003 Aug 1;59(2):479-87 - PubMed
  22. J Nutr. 2003 Jun;133(6):1806-14 - PubMed
  23. Cell Death Dis. 2010;1:e19 - PubMed
  24. Endocrinology. 1998 Oct;139(10):4252-63 - PubMed
  25. Br J Cancer. 2004 Jul 5;91(1):99-105 - PubMed
  26. Xenobiotica. 2001 Dec;31(12):841-7 - PubMed
  27. Prostate. 2008 Jan 1;68(1):61-71 - PubMed
  28. J Agric Food Chem. 2010 Jan 27;58(2):814-20 - PubMed
  29. Biochem Pharmacol. 1997 Jun 1;53(11):1649-57 - PubMed
  30. Ophthalmologe. 1997 Feb;94(2):152-6 - PubMed
  31. Biochem J. 1996 Jan 1;313 ( Pt 1):17-29 - PubMed
  32. Food Chem Toxicol. 1999 Sep-Oct;37(9-10):937-42 - PubMed
  33. Mini Rev Med Chem. 2011 Feb;11(2):169-77 - PubMed
  34. Biochemistry. 1999 Feb 9;38(6):1736-43 - PubMed
  35. Scanning. 2012 Jan-Feb;34(1):1-5 - PubMed
  36. J Nutr. 2003 Nov;133(11 Suppl 1):3773S-3777S - PubMed
  37. Mol Cell Biochem. 2004 Nov;266(1-2):37-56 - PubMed
  38. Biochem Pharmacol. 2005 Jan 15;69(2):307-18 - PubMed
  39. Toxicol Sci. 2004 Jul;80(1):14-25 - PubMed
  40. Eur J Cancer. 2004 Jan;40(1):84-9 - PubMed
  41. J Nutr. 2008 Aug;138(8):1561S-1566S - PubMed
  42. Nat Rev Cancer. 2004 Oct;4(10 ):793-805 - PubMed
  43. Mol Cell Biol. 2005 Sep;25(17):7423-31 - PubMed
  44. Prostate. 1998 Sep 15;37(1):36-43 - PubMed
  45. Int J Cancer. 2000 Aug 15;87(4):595-600 - PubMed
  46. Br J Nutr. 2004 Jun;91(6):849-55 - PubMed
  47. Chem Biol Interact. 2002 Jan 22;139(1):1-21 - PubMed
  48. Cancer Lett. 2009 Feb 8;274(1):33-9 - PubMed
  49. J Nutr. 2002 Oct;132(10 ):3036-41 - PubMed
  50. Molecules. 2008 Oct 22;13(10):2628-51 - PubMed
  51. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):339-44 - PubMed
  52. Am J Epidemiol. 2009 Sep 15;170(6):717-29 - PubMed
  53. Cell Mol Life Sci. 2002 Feb;59(2):307-22 - PubMed
  54. Nat Cell Biol. 2002 May;4(5):E131-6 - PubMed
  55. J Nutr. 1995 Mar;125(3 Suppl):790S-797S - PubMed
  56. Expert Opin Drug Metab Toxicol. 2008 Jan;4(1):17-35 - PubMed
  57. J Exp Bot. 2012 May;63(9):3429-44 - PubMed
  58. Am J Clin Nutr. 2000 Aug;72(2):395-400 - PubMed
  59. Public Health Nutr. 2000 Sep;3(3):263-71 - PubMed
  60. Biochem Pharmacol. 2007 Aug 15;74(4):533-44 - PubMed
  61. Cancer Lett. 2005 Apr 18;221(1):97-104 - PubMed
  62. Expert Rev Mol Med. 2009 Oct 30;11:e32 - PubMed
  63. Mol Cancer Ther. 2005 Jan;4(1):81-90 - PubMed
  64. Xenobiotica. 2006 Jan;36(1):41-58 - PubMed
  65. Microbiology. 2007 Oct;153(Pt 10):3314-22 - PubMed
  66. J Agric Food Chem. 2002 Sep 25;50(20):5735-41 - PubMed
  67. Toxicol In Vitro. 2011 Apr;25(3):630-5 - PubMed
  68. FEBS Lett. 1997 Jun 2;409(1):12-6 - PubMed
  69. Cancer Cell Int. 2010 May 11;10:16 - PubMed
  70. Food Chem Toxicol. 2008 Jun;46(6):2042-53 - PubMed
  71. Cancer Causes Control. 2008 Oct;19(8):813-8 - PubMed
  72. Mol Pharmacol. 1998 Jul;54(1):105-12 - PubMed
  73. Cancer Sci. 2011 Jan;102(1):219-25 - PubMed
  74. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9831-6 - PubMed
  75. Xenobiotica. 2002 Jul;32(7):587-94 - PubMed
  76. Cancer Res. 2008 Mar 15;68(6):2024-32 - PubMed
  77. Cancer Res. 1998 May 1;58(9):1920-9 - PubMed
  78. Am J Clin Nutr. 2004 Jul;80(1):15-21 - PubMed
  79. Am J Clin Nutr. 2008 Dec;88(6):1653-62 - PubMed
  80. Cancer Lett. 1998 Nov 13;133(1):101-6 - PubMed
  81. Mol Cell Biochem. 2008 Jun;313(1-2):125-32 - PubMed
  82. FEBS Lett. 1992 Apr 27;301(3):307-9 - PubMed
  83. Cancer Res. 2006 May 1;66(9):4816-25 - PubMed
  84. Drug Metab Dispos. 2001 Jun;29(6):789-93 - PubMed
  85. BMC Complement Altern Med. 2011 Sep 20;11:76 - PubMed
  86. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1418S-1425S - PubMed
  87. Planta Med. 2004 Dec;70(12):1103-14 - PubMed
  88. J Agric Food Chem. 2000 Nov;48(11):5331-7 - PubMed
  89. Biochemistry. 2004 Sep 28;43(38):12123-32 - PubMed
  90. Arch Biochem Biophys. 2005 Jan 15;433(2):421-7 - PubMed
  91. J Natl Cancer Inst. 2000 Jan 19;92 (2):154-60 - PubMed
  92. Drug Metab Dispos. 2003 Jun;31(6):805-13 - PubMed
  93. J Nat Prod. 1996 Feb;59(2):205-15 - PubMed
  94. Bull Exp Biol Med. 2009 Jul;148(1):57-9 - PubMed
  95. Cancer Causes Control. 2002 May;13(4):373-82 - PubMed
  96. Chin J Integr Med. 2011 Jun;17(6):459-63 - PubMed
  97. Biomacromolecules. 2003 May-Jun;4(3):469-71 - PubMed
  98. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):223-8 - PubMed
  99. J Nutr. 2000 Sep;130(9):2243-50 - PubMed
  100. Cancer Res. 2006 May 1;66(9):4826-34 - PubMed
  101. BMC Complement Altern Med. 2010 Sep 17;10:51 - PubMed
  102. Cancer Res. 1990 Feb 1;50(3):499-502 - PubMed
  103. Lancet. 1992 Jun 20;339(8808):1523-6 - PubMed
  104. Am J Clin Nutr. 2002 Sep;76(3):560-8 - PubMed
  105. J Nutr. 2001 Oct;131(10):2648-52 - PubMed
  106. Cancer Lett. 2009 Feb 18;274(2):290-8 - PubMed
  107. Nutr Cancer. 1999;35(2):175-9 - PubMed
  108. Biol Pharm Bull. 1996 Feb;19(2):326-9 - PubMed
  109. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):559-79 - PubMed
  110. EMBO J. 1999 Sep 1;18(17):4608-18 - PubMed
  111. Neuro Endocrinol Lett. 2009;30 Suppl 1:67-71 - PubMed
  112. Cancer Res. 1997 Jul 15;57(14):2916-21 - PubMed
  113. Oral Oncol. 1999 Jan;35(1):22-6 - PubMed
  114. Nutr Cancer. 2010;62(7):871-7 - PubMed
  115. Curr Drug Metab. 2009 May;10(4):369-94 - PubMed
  116. Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5419-24 - PubMed
  117. BMJ. 1996 Feb 24;312(7029):478-81 - PubMed
  118. J Surg Res. 2011 Sep;170(1):84-8 - PubMed
  119. Prostate Cancer Prostatic Dis. 2007;10(3):216-23 - PubMed
  120. Drug Metab Dispos. 2002 May;30(5):564-9 - PubMed
  121. Basic Clin Pharmacol Toxicol. 2011 Feb;108(2):84-93 - PubMed
  122. J Nutr. 2006 Jun;136(6):1477-82 - PubMed
  123. Eur J Pharm Sci. 2005 Jun;25(2-3):263-71 - PubMed
  124. Molecules. 2010 Apr 29;15(5):3135-70 - PubMed
  125. J Nutr. 2004 Jan;134(1):179-82 - PubMed
  126. J Cell Biochem. 2003 Jun 1;89(3):529-38 - PubMed
  127. Biochem Pharmacol. 2001 May 15;61(10):1205-15 - PubMed
  128. Biochem Pharmacol. 2004 Mar 1;67(5):989-1000 - PubMed
  129. Nutr Cancer. 1994;21(2):113-31 - PubMed
  130. Breast Cancer Res. 2004;6(3):R170-9 - PubMed
  131. Nutr Cancer. 2004;50(1):90-100 - PubMed
  132. Endocrinology. 1997 Mar;138(3):863-70 - PubMed
  133. Curr Opin Urol. 2005 Jan;15(1):17-22 - PubMed
  134. Am J Clin Nutr. 2002 Jul;76(1):93-9 - PubMed
  135. FASEB J. 2002 Jan;16(1):2-14 - PubMed
  136. Pharmacol Ther. 2002 Nov-Dec;96(2-3):67-202 - PubMed
  137. Biochem Biophys Res Commun. 2002 May 24;293(5):1458-65 - PubMed
  138. Cancer Lett. 2001 Oct 22;172(1):1-6 - PubMed
  139. Lancet. 1997 Oct 4;350(9083):990-4 - PubMed
  140. Nat Genet. 1996 Jun;13(2):189-95 - PubMed
  141. J Dent Res. 2008 Apr;87(4):401-6 - PubMed
  142. Mol Cancer Ther. 2006 Sep;5(9):2261-70 - PubMed
  143. Phytochemistry. 2000 Nov;55(6):481-504 - PubMed
  144. Angiologica. 1972;9(3-6):162-74 - PubMed
  145. J Pharm Sci. 2010 Feb;99(2):598-617 - PubMed
  146. Nutr Cancer. 1999;34(1):100-10 - PubMed
  147. J Nutr. 2003 Jul;133(7):2184-7 - PubMed
  148. Life Sci. 2006 Mar 27;78(18):2116-30 - PubMed
  149. Biotechnol J. 2007 Oct;2(10):1214-34 - PubMed
  150. Free Radic Biol Med. 2004 Apr 1;36(7):838-49 - PubMed
  151. J Nutr. 2004 Jun;134(6):1529-35 - PubMed
  152. Arch Biochem Biophys. 1998 Dec 1;360(1):142-8 - PubMed
  153. Xenobiotica. 2002 May;32(5):363-8 - PubMed
  154. J Clin Oncol. 2009 Jun 1;27(16):2712-25 - PubMed
  155. Mol Pharmacol. 2007 May;71(5):1381-8 - PubMed
  156. Methods Enzymol. 1994;234:410-20 - PubMed
  157. Biochem J. 2001 Sep 15;358(Pt 3):547-57 - PubMed
  158. Pharmacol Ther. 2001 May-Jun;90(2-3):157-77 - PubMed
  159. Gen Pharmacol. 1999 Mar;32(3):279-86 - PubMed
  160. Cancer Res. 1998 Nov 15;58(22):5231-8 - PubMed
  161. Science. 2000 Mar 10;287(5459):1765-6 - PubMed
  162. J Pharm Pharmacol. 2004 Aug;56(8):1039-44 - PubMed
  163. Toxicol In Vitro. 2012 Feb;26(1):67-73 - PubMed
  164. Oncol Rep. 2008 Apr;19(4):1061-6 - PubMed
  165. Nutr Cancer. 2009;61(5):717-22 - PubMed
  166. Phytochemistry. 2004 May;65(10):1317-30 - PubMed
  167. Gen Physiol Biophys. 2006 Dec;25(4):379-96 - PubMed
  168. Cancer Res. 2004 Nov 1;64(21):7936-46 - PubMed
  169. Am J Pathol. 2007 Dec;171(6):2021-32 - PubMed
  170. Carcinogenesis. 2000 May;21(5):937-41 - PubMed
  171. Neurobiol Aging. 2002 Sep-Oct;23(5):861-80 - PubMed
  172. J Exp Clin Cancer Res. 2009 Jun 11;28:80 - PubMed
  173. Biochem Biophys Res Commun. 2004 Jan 2;313(1):148-55 - PubMed
  174. J Nutr. 2000 May;130(5):1200-3 - PubMed
  175. Chem Rev. 2001 Aug;101(8):2541-72 - PubMed
  176. Nutr Cancer. 2004;50(1):1-7 - PubMed
  177. Carcinogenesis. 2003 Oct;24(10):1651-6 - PubMed
  178. Mutat Res. 2004 Jul 13;551(1-2):9-28 - PubMed
  179. CA Cancer J Clin. 2004 May-Jun;54(3):150-80 - PubMed
  180. Br J Cancer. 2003 Oct 6;89(7):1255-9 - PubMed
  181. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1621-5 - PubMed
  182. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2690-4 - PubMed
  183. Prostate. 2005 Feb 1;62(2):200-7 - PubMed
  184. Endocrinology. 2008 Jan;149(1):84-92 - PubMed
  185. Int J Cancer. 2004 Sep 1;111(3):440-3 - PubMed
  186. J Agric Food Chem. 2002 Mar 13;50(6):1404-10 - PubMed
  187. Cell Mol Life Sci. 2001 May;58(5-6):737-47 - PubMed
  188. Toxicology. 2000 Apr 3;144(1-3):31-8 - PubMed
  189. Leukemia. 2001 Jun;15(6):936-41 - PubMed
  190. J Invest Dermatol. 2004 Sep;123(3):417-25 - PubMed
  191. PLoS One. 2012;7(2):e31060 - PubMed
  192. Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):553-62 - PubMed
  193. Biochem Biophys Res Commun. 1998 Apr 17;245(2):435-8 - PubMed
  194. Molecules. 2011 Mar 11;16(3):2348-64 - PubMed
  195. Life Sci. 2005 Jan 28;76(11):1267-79 - PubMed
  196. Cancer Causes Control. 1999 Feb;10(1):71-5 - PubMed
  197. Evid Based Complement Alternat Med. 2011;2011:591356 - PubMed
  198. Proc Soc Exp Biol Med. 1995 Jan;208(1):124-30 - PubMed
  199. Ann N Y Acad Sci. 2001 Dec;948:51-66 - PubMed
  200. Anticancer Res. 1998 Jul-Aug;18(4A):2449-53 - PubMed
  201. Arch Biochem Biophys. 2002 Oct 15;406(2):173-82 - PubMed
  202. J Antibiot (Tokyo). 1992 Jul;45(7):1155-60 - PubMed
  203. Curr Med Chem. 2004 May;11(9):1163-82 - PubMed
  204. J Nutr. 2008 Jun;138(6):1244S-9S - PubMed
  205. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):815-21 - PubMed
  206. Pharm Res. 2001 Mar;18(3):374-9 - PubMed
  207. Cancer Res. 2002 Feb 15;62(4):1025-9 - PubMed
  208. Eur J Pharm Sci. 2012 Apr 11;45(5):648-56 - PubMed
  209. Am J Clin Nutr. 1999 Jan;69(1):87-94 - PubMed
  210. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):98-101 - PubMed
  211. Am J Clin Nutr. 2005 Jan;81(1 Suppl):317S-325S - PubMed
  212. Biochem J. 1999 Jun 15;340 ( Pt 3):715-22 - PubMed
  213. Invest Ophthalmol Vis Sci. 2009 May;50(5):2398-406 - PubMed
  214. J Nutr. 2000 Aug;130(8S Suppl):2073S-85S - PubMed
  215. Cancer Lett. 1997 Jan 30;112(2):127-33 - PubMed

Publication Types